nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—KCNK1—brainstem—malignant glioma	0.0168	0.0556	CbGeAlD
Quinidine barbiturate—GRIA2—embryo—malignant glioma	0.0149	0.0494	CbGeAlD
Quinidine barbiturate—KCNK1—telencephalon—malignant glioma	0.0149	0.0493	CbGeAlD
Quinidine barbiturate—Disorder sight—Temozolomide—malignant glioma	0.0143	0.0259	CcSEcCtD
Quinidine barbiturate—GRIA2—brainstem—malignant glioma	0.0136	0.0452	CbGeAlD
Quinidine barbiturate—Azotaemia—Carmustine—malignant glioma	0.0132	0.0239	CcSEcCtD
Quinidine barbiturate—GRIA2—telencephalon—malignant glioma	0.0121	0.0401	CbGeAlD
Quinidine barbiturate—KCNK1—medulla oblongata—malignant glioma	0.0117	0.0388	CbGeAlD
Quinidine barbiturate—Myasthenia—Carmustine—malignant glioma	0.0112	0.0203	CcSEcCtD
Quinidine barbiturate—Quinidine—CYP2B6—malignant glioma	0.0109	0.485	CrCbGaD
Quinidine barbiturate—Aphasia—Carmustine—malignant glioma	0.0108	0.0197	CcSEcCtD
Quinidine barbiturate—KCNK1—midbrain—malignant glioma	0.0107	0.0354	CbGeAlD
Quinidine barbiturate—Aphasia—Temozolomide—malignant glioma	0.0105	0.019	CcSEcCtD
Quinidine barbiturate—KCNK1—spinal cord—malignant glioma	0.0104	0.0346	CbGeAlD
Quinidine barbiturate—Scotoma—Carmustine—malignant glioma	0.00927	0.0168	CcSEcCtD
Quinidine barbiturate—Hepatotoxicity—Carmustine—malignant glioma	0.00911	0.0165	CcSEcCtD
Quinidine barbiturate—Necrosis—Carmustine—malignant glioma	0.00896	0.0162	CcSEcCtD
Quinidine barbiturate—Scotoma—Temozolomide—malignant glioma	0.00895	0.0162	CcSEcCtD
Quinidine barbiturate—GABRA2—brainstem—malignant glioma	0.00886	0.0294	CbGeAlD
Quinidine barbiturate—Hepatotoxicity—Temozolomide—malignant glioma	0.00881	0.016	CcSEcCtD
Quinidine barbiturate—Coagulopathy—Temozolomide—malignant glioma	0.00873	0.0158	CcSEcCtD
Quinidine barbiturate—GRIA2—midbrain—malignant glioma	0.00869	0.0288	CbGeAlD
Quinidine barbiturate—GABRA1—brainstem—malignant glioma	0.00856	0.0284	CbGeAlD
Quinidine barbiturate—GRIA2—spinal cord—malignant glioma	0.00848	0.0281	CbGeAlD
Quinidine barbiturate—KCNK1—central nervous system—malignant glioma	0.00845	0.028	CbGeAlD
Quinidine barbiturate—Petechiae—Temozolomide—malignant glioma	0.00827	0.015	CcSEcCtD
Quinidine barbiturate—KCNK1—cerebellum—malignant glioma	0.00826	0.0274	CbGeAlD
Quinidine barbiturate—Liver injury—Temozolomide—malignant glioma	0.00808	0.0146	CcSEcCtD
Quinidine barbiturate—Extravasation—Carmustine—malignant glioma	0.00806	0.0146	CcSEcCtD
Quinidine barbiturate—GABRA2—telencephalon—malignant glioma	0.00786	0.0261	CbGeAlD
Quinidine barbiturate—Thinking abnormal—Carmustine—malignant glioma	0.00769	0.0139	CcSEcCtD
Quinidine barbiturate—GABRA1—telencephalon—malignant glioma	0.0076	0.0252	CbGeAlD
Quinidine barbiturate—CHRM2—telencephalon—malignant glioma	0.00756	0.0251	CbGeAlD
Quinidine barbiturate—Hearing impaired—Temozolomide—malignant glioma	0.00714	0.0129	CcSEcCtD
Quinidine barbiturate—Injection site reaction—Carmustine—malignant glioma	0.00699	0.0127	CcSEcCtD
Quinidine barbiturate—Respiratory failure—Temozolomide—malignant glioma	0.00692	0.0125	CcSEcCtD
Quinidine barbiturate—GRIA2—central nervous system—malignant glioma	0.00688	0.0228	CbGeAlD
Quinidine barbiturate—Depressed level of consciousness—Carmustine—malignant glioma	0.00679	0.0123	CcSEcCtD
Quinidine barbiturate—GRIA2—cerebellum—malignant glioma	0.00672	0.0223	CbGeAlD
Quinidine barbiturate—KCNK1—brain—malignant glioma	0.00671	0.0223	CbGeAlD
Quinidine barbiturate—Phenobarbital—CYP2C18—malignant glioma	0.00668	0.296	CrCbGaD
Quinidine barbiturate—Depressed level of consciousness—Temozolomide—malignant glioma	0.00657	0.0119	CcSEcCtD
Quinidine barbiturate—Coma—Carmustine—malignant glioma	0.00643	0.0116	CcSEcCtD
Quinidine barbiturate—Aplastic anaemia—Temozolomide—malignant glioma	0.00638	0.0116	CcSEcCtD
Quinidine barbiturate—Mental disability—Carmustine—malignant glioma	0.00611	0.0111	CcSEcCtD
Quinidine barbiturate—GABRA1—medulla oblongata—malignant glioma	0.00597	0.0198	CbGeAlD
Quinidine barbiturate—Mental disability—Temozolomide—malignant glioma	0.0059	0.0107	CcSEcCtD
Quinidine barbiturate—Deafness—Temozolomide—malignant glioma	0.00552	0.01	CcSEcCtD
Quinidine barbiturate—GRIA2—brain—malignant glioma	0.00546	0.0181	CbGeAlD
Quinidine barbiturate—KCNH2—telencephalon—malignant glioma	0.00546	0.0181	CbGeAlD
Quinidine barbiturate—GABRA1—midbrain—malignant glioma	0.00546	0.0181	CbGeAlD
Quinidine barbiturate—GABRA1—spinal cord—malignant glioma	0.00532	0.0177	CbGeAlD
Quinidine barbiturate—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00523	0.00948	CcSEcCtD
Quinidine barbiturate—Purpura—Temozolomide—malignant glioma	0.00512	0.00928	CcSEcCtD
Quinidine barbiturate—Diplopia—Carmustine—malignant glioma	0.00511	0.00925	CcSEcCtD
Quinidine barbiturate—SCN5A—central nervous system—malignant glioma	0.00505	0.0167	CbGeAlD
Quinidine barbiturate—Phenobarbital—CYP2B6—malignant glioma	0.00496	0.22	CrCbGaD
Quinidine barbiturate—Diplopia—Temozolomide—malignant glioma	0.00494	0.00894	CcSEcCtD
Quinidine barbiturate—Affect lability—Temozolomide—malignant glioma	0.00486	0.0088	CcSEcCtD
Quinidine barbiturate—Ataxia—Carmustine—malignant glioma	0.0048	0.0087	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Carmustine—malignant glioma	0.00472	0.00854	CcSEcCtD
Quinidine barbiturate—Mood swings—Temozolomide—malignant glioma	0.00468	0.00847	CcSEcCtD
Quinidine barbiturate—Ataxia—Temozolomide—malignant glioma	0.00464	0.00841	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Carmustine—malignant glioma	0.0045	0.00816	CcSEcCtD
Quinidine barbiturate—GABRA2—central nervous system—malignant glioma	0.00447	0.0148	CbGeAlD
Quinidine barbiturate—Breast disorder—Temozolomide—malignant glioma	0.00446	0.00808	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00444	0.00805	CcSEcCtD
Quinidine barbiturate—GABRA2—cerebellum—malignant glioma	0.00437	0.0145	CbGeAlD
Quinidine barbiturate—Muscular weakness—Temozolomide—malignant glioma	0.00435	0.00789	CcSEcCtD
Quinidine barbiturate—GABRA1—central nervous system—malignant glioma	0.00432	0.0143	CbGeAlD
Quinidine barbiturate—CHRM2—central nervous system—malignant glioma	0.0043	0.0143	CbGeAlD
Quinidine barbiturate—KCNH2—medulla oblongata—malignant glioma	0.00429	0.0142	CbGeAlD
Quinidine barbiturate—GABRA1—cerebellum—malignant glioma	0.00422	0.014	CbGeAlD
Quinidine barbiturate—Pancytopenia—Carmustine—malignant glioma	0.00419	0.0076	CcSEcCtD
Quinidine barbiturate—Neutropenia—Carmustine—malignant glioma	0.00413	0.00748	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Temozolomide—malignant glioma	0.00405	0.00734	CcSEcCtD
Quinidine barbiturate—SCN5A—brain—malignant glioma	0.00401	0.0133	CbGeAlD
Quinidine barbiturate—Neutropenia—Temozolomide—malignant glioma	0.00399	0.00723	CcSEcCtD
Quinidine barbiturate—KCNH2—midbrain—malignant glioma	0.00392	0.013	CbGeAlD
Quinidine barbiturate—Photosensitivity reaction—Temozolomide—malignant glioma	0.00389	0.00705	CcSEcCtD
Quinidine barbiturate—Renal failure—Carmustine—malignant glioma	0.00387	0.00701	CcSEcCtD
Quinidine barbiturate—KCNH2—spinal cord—malignant glioma	0.00383	0.0127	CbGeAlD
Quinidine barbiturate—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00377	0.00683	CcSEcCtD
Quinidine barbiturate—CYP2D6—brainstem—malignant glioma	0.00375	0.0124	CbGeAlD
Quinidine barbiturate—Haemoglobin—Carmustine—malignant glioma	0.00355	0.00643	CcSEcCtD
Quinidine barbiturate—GABRA2—brain—malignant glioma	0.00355	0.0118	CbGeAlD
Quinidine barbiturate—Haemorrhage—Carmustine—malignant glioma	0.00353	0.0064	CcSEcCtD
Quinidine barbiturate—Hallucination—Carmustine—malignant glioma	0.00352	0.00637	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Temozolomide—malignant glioma	0.00343	0.00622	CcSEcCtD
Quinidine barbiturate—GABRA1—brain—malignant glioma	0.00343	0.0114	CbGeAlD
Quinidine barbiturate—Haemorrhage—Temozolomide—malignant glioma	0.00341	0.00619	CcSEcCtD
Quinidine barbiturate—Hepatitis—Temozolomide—malignant glioma	0.00341	0.00619	CcSEcCtD
Quinidine barbiturate—CHRM2—brain—malignant glioma	0.00341	0.0113	CbGeAlD
Quinidine barbiturate—Visual impairment—Carmustine—malignant glioma	0.00341	0.00617	CcSEcCtD
Quinidine barbiturate—Hallucination—Temozolomide—malignant glioma	0.0034	0.00616	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Temozolomide—malignant glioma	0.00337	0.00611	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Temozolomide—malignant glioma	0.00335	0.00606	CcSEcCtD
Quinidine barbiturate—CYP2D6—telencephalon—malignant glioma	0.00333	0.011	CbGeAlD
Quinidine barbiturate—Eye disorder—Carmustine—malignant glioma	0.0033	0.00598	CcSEcCtD
Quinidine barbiturate—Visual impairment—Temozolomide—malignant glioma	0.00329	0.00596	CcSEcCtD
Quinidine barbiturate—Flushing—Carmustine—malignant glioma	0.00328	0.00594	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Temozolomide—malignant glioma	0.00323	0.00585	CcSEcCtD
Quinidine barbiturate—Eye disorder—Temozolomide—malignant glioma	0.00319	0.00578	CcSEcCtD
Quinidine barbiturate—Tinnitus—Temozolomide—malignant glioma	0.00318	0.00577	CcSEcCtD
Quinidine barbiturate—Flushing—Temozolomide—malignant glioma	0.00317	0.00574	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Temozolomide—malignant glioma	0.00317	0.00574	CcSEcCtD
Quinidine barbiturate—KCNH2—central nervous system—malignant glioma	0.0031	0.0103	CbGeAlD
Quinidine barbiturate—Mental disorder—Carmustine—malignant glioma	0.0031	0.00561	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Temozolomide—malignant glioma	0.00308	0.00559	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Temozolomide—malignant glioma	0.00308	0.00558	CcSEcCtD
Quinidine barbiturate—Erythema—Carmustine—malignant glioma	0.00308	0.00557	CcSEcCtD
Quinidine barbiturate—Malnutrition—Carmustine—malignant glioma	0.00308	0.00557	CcSEcCtD
Quinidine barbiturate—Chills—Temozolomide—malignant glioma	0.00306	0.00555	CcSEcCtD
Quinidine barbiturate—KCNH2—cerebellum—malignant glioma	0.00303	0.0101	CbGeAlD
Quinidine barbiturate—Mental disorder—Temozolomide—malignant glioma	0.00299	0.00542	CcSEcCtD
Quinidine barbiturate—Erythema—Temozolomide—malignant glioma	0.00297	0.00539	CcSEcCtD
Quinidine barbiturate—Malnutrition—Temozolomide—malignant glioma	0.00297	0.00539	CcSEcCtD
Quinidine barbiturate—Vision blurred—Carmustine—malignant glioma	0.0029	0.00525	CcSEcCtD
Quinidine barbiturate—Tremor—Carmustine—malignant glioma	0.00288	0.00522	CcSEcCtD
Quinidine barbiturate—Agitation—Carmustine—malignant glioma	0.00283	0.00512	CcSEcCtD
Quinidine barbiturate—Vision blurred—Temozolomide—malignant glioma	0.0028	0.00508	CcSEcCtD
Quinidine barbiturate—Tremor—Temozolomide—malignant glioma	0.00278	0.00505	CcSEcCtD
Quinidine barbiturate—Leukopenia—Carmustine—malignant glioma	0.00275	0.00499	CcSEcCtD
Quinidine barbiturate—Agitation—Temozolomide—malignant glioma	0.00273	0.00495	CcSEcCtD
Quinidine barbiturate—Angioedema—Temozolomide—malignant glioma	0.00272	0.00492	CcSEcCtD
Quinidine barbiturate—Vertigo—Temozolomide—malignant glioma	0.00267	0.00484	CcSEcCtD
Quinidine barbiturate—Convulsion—Carmustine—malignant glioma	0.00267	0.00483	CcSEcCtD
Quinidine barbiturate—Leukopenia—Temozolomide—malignant glioma	0.00266	0.00482	CcSEcCtD
Quinidine barbiturate—Palpitations—Temozolomide—malignant glioma	0.00263	0.00476	CcSEcCtD
Quinidine barbiturate—Myalgia—Carmustine—malignant glioma	0.00262	0.00474	CcSEcCtD
Quinidine barbiturate—Chest pain—Carmustine—malignant glioma	0.00262	0.00474	CcSEcCtD
Quinidine barbiturate—Anxiety—Carmustine—malignant glioma	0.00261	0.00473	CcSEcCtD
Quinidine barbiturate—Convulsion—Temozolomide—malignant glioma	0.00258	0.00467	CcSEcCtD
Quinidine barbiturate—Confusional state—Carmustine—malignant glioma	0.00253	0.00459	CcSEcCtD
Quinidine barbiturate—Arthralgia—Temozolomide—malignant glioma	0.00253	0.00458	CcSEcCtD
Quinidine barbiturate—Myalgia—Temozolomide—malignant glioma	0.00253	0.00458	CcSEcCtD
Quinidine barbiturate—Anxiety—Temozolomide—malignant glioma	0.00252	0.00457	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00251	0.00455	CcSEcCtD
Quinidine barbiturate—Oedema—Carmustine—malignant glioma	0.00251	0.00455	CcSEcCtD
Quinidine barbiturate—KCNH2—brain—malignant glioma	0.00246	0.00817	CbGeAlD
Quinidine barbiturate—Thrombocytopenia—Carmustine—malignant glioma	0.00246	0.00445	CcSEcCtD
Quinidine barbiturate—Tachycardia—Carmustine—malignant glioma	0.00245	0.00444	CcSEcCtD
Quinidine barbiturate—Confusional state—Temozolomide—malignant glioma	0.00245	0.00443	CcSEcCtD
Quinidine barbiturate—Oedema—Temozolomide—malignant glioma	0.00243	0.0044	CcSEcCtD
Quinidine barbiturate—Anorexia—Carmustine—malignant glioma	0.00239	0.00434	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Temozolomide—malignant glioma	0.00238	0.00431	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Temozolomide—malignant glioma	0.00238	0.0043	CcSEcCtD
Quinidine barbiturate—Skin disorder—Temozolomide—malignant glioma	0.00236	0.00427	CcSEcCtD
Quinidine barbiturate—Hypotension—Carmustine—malignant glioma	0.00235	0.00425	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Temozolomide—malignant glioma	0.00235	0.00425	CcSEcCtD
Quinidine barbiturate—Anorexia—Temozolomide—malignant glioma	0.00231	0.00419	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00229	0.00414	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Carmustine—malignant glioma	0.00224	0.00405	CcSEcCtD
Quinidine barbiturate—Somnolence—Carmustine—malignant glioma	0.00223	0.00404	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00221	0.004	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Carmustine—malignant glioma	0.00218	0.00395	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Carmustine—malignant glioma	0.00217	0.00393	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Temozolomide—malignant glioma	0.00216	0.00392	CcSEcCtD
Quinidine barbiturate—Somnolence—Temozolomide—malignant glioma	0.00216	0.00391	CcSEcCtD
Quinidine barbiturate—Constipation—Carmustine—malignant glioma	0.00215	0.00389	CcSEcCtD
Quinidine barbiturate—Pain—Carmustine—malignant glioma	0.00215	0.00389	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Temozolomide—malignant glioma	0.00211	0.00382	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00209	0.00379	CcSEcCtD
Quinidine barbiturate—Pain—Temozolomide—malignant glioma	0.00207	0.00376	CcSEcCtD
Quinidine barbiturate—Constipation—Temozolomide—malignant glioma	0.00207	0.00376	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Carmustine—malignant glioma	0.00207	0.00375	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Carmustine—malignant glioma	0.00205	0.00372	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Temozolomide—malignant glioma	0.002	0.00362	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Carmustine—malignant glioma	0.00198	0.0036	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Carmustine—malignant glioma	0.00198	0.0036	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Temozolomide—malignant glioma	0.00198	0.00359	CcSEcCtD
Quinidine barbiturate—Urticaria—Temozolomide—malignant glioma	0.00193	0.00349	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Temozolomide—malignant glioma	0.00192	0.00347	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Temozolomide—malignant glioma	0.00192	0.00347	CcSEcCtD
Quinidine barbiturate—CYP2D6—central nervous system—malignant glioma	0.00189	0.00628	CbGeAlD
Quinidine barbiturate—CYP2D6—cerebellum—malignant glioma	0.00185	0.00614	CbGeAlD
Quinidine barbiturate—Hypersensitivity—Carmustine—malignant glioma	0.00185	0.00335	CcSEcCtD
Quinidine barbiturate—Asthenia—Carmustine—malignant glioma	0.0018	0.00326	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Temozolomide—malignant glioma	0.00179	0.00324	CcSEcCtD
Quinidine barbiturate—Asthenia—Temozolomide—malignant glioma	0.00174	0.00315	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Carmustine—malignant glioma	0.00172	0.00311	CcSEcCtD
Quinidine barbiturate—Pruritus—Temozolomide—malignant glioma	0.00172	0.00311	CcSEcCtD
Quinidine barbiturate—Dizziness—Carmustine—malignant glioma	0.00166	0.00301	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Temozolomide—malignant glioma	0.00166	0.00301	CcSEcCtD
Quinidine barbiturate—Dizziness—Temozolomide—malignant glioma	0.0016	0.00291	CcSEcCtD
Quinidine barbiturate—Vomiting—Carmustine—malignant glioma	0.0016	0.00289	CcSEcCtD
Quinidine barbiturate—Rash—Carmustine—malignant glioma	0.00158	0.00287	CcSEcCtD
Quinidine barbiturate—Dermatitis—Carmustine—malignant glioma	0.00158	0.00286	CcSEcCtD
Quinidine barbiturate—Headache—Carmustine—malignant glioma	0.00157	0.00285	CcSEcCtD
Quinidine barbiturate—Vomiting—Temozolomide—malignant glioma	0.00154	0.00279	CcSEcCtD
Quinidine barbiturate—Rash—Temozolomide—malignant glioma	0.00153	0.00277	CcSEcCtD
Quinidine barbiturate—Dermatitis—Temozolomide—malignant glioma	0.00153	0.00277	CcSEcCtD
Quinidine barbiturate—Headache—Temozolomide—malignant glioma	0.00152	0.00275	CcSEcCtD
Quinidine barbiturate—CYP2D6—brain—malignant glioma	0.0015	0.00499	CbGeAlD
Quinidine barbiturate—Nausea—Carmustine—malignant glioma	0.00149	0.0027	CcSEcCtD
Quinidine barbiturate—Nausea—Temozolomide—malignant glioma	0.00144	0.00261	CcSEcCtD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000275	0.00221	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000272	0.0022	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000272	0.00219	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000272	0.00219	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000271	0.00219	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000269	0.00217	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—STAT3—malignant glioma	0.000266	0.00215	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PDGFRA—malignant glioma	0.000265	0.00214	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000263	0.00212	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000263	0.00212	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.00026	0.00209	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.000258	0.00208	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000255	0.00206	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000254	0.00205	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—BDKRB2—malignant glioma	0.000254	0.00205	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—BRAF—malignant glioma	0.000249	0.00201	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—FGFR1—malignant glioma	0.000247	0.00199	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PDGFB—malignant glioma	0.000238	0.00192	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—FGFR1—malignant glioma	0.000237	0.00191	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.000236	0.0019	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTT1—malignant glioma	0.000234	0.00189	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—KDR—malignant glioma	0.000233	0.00188	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—KNG1—malignant glioma	0.000231	0.00186	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.00023	0.00185	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000229	0.00185	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MET—malignant glioma	0.000228	0.00184	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Ion channel transport—RAF1—malignant glioma	0.000226	0.00182	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCR4—malignant glioma	0.000226	0.00182	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000225	0.00182	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000223	0.0018	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.000221	0.00178	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—BRAF—malignant glioma	0.00022	0.00177	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—PTGS1—malignant glioma	0.000219	0.00177	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000218	0.00175	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000217	0.00175	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—F2—malignant glioma	0.000215	0.00173	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—FN1—malignant glioma	0.000215	0.00173	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PTK2—malignant glioma	0.000211	0.0017	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—PTPN11—malignant glioma	0.000211	0.0017	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—MDM2—malignant glioma	0.000209	0.00168	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—RAF1—malignant glioma	0.000208	0.00168	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—HES1—malignant glioma	0.000207	0.00167	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—NCOR1—malignant glioma	0.000206	0.00166	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CG—malignant glioma	0.000206	0.00166	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—APC—malignant glioma	0.000206	0.00166	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—EGF—malignant glioma	0.000203	0.00164	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.000202	0.00163	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000199	0.0016	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000197	0.00159	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000195	0.00157	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—BRAF—malignant glioma	0.000193	0.00156	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LATS2—malignant glioma	0.000193	0.00156	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Ion channel transport—RAF1—malignant glioma	0.000193	0.00156	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000192	0.00155	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000191	0.00154	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000191	0.00154	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MMP2—malignant glioma	0.00019	0.00153	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000187	0.0015	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—MDM2—malignant glioma	0.000184	0.00149	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—RAF1—malignant glioma	0.000184	0.00148	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.000184	0.00148	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000183	0.00147	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CD—malignant glioma	0.000181	0.00146	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000179	0.00144	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000179	0.00144	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—FGFR1—malignant glioma	0.000176	0.00142	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—BRAF—malignant glioma	0.000175	0.00141	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000174	0.0014	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—FGF2—malignant glioma	0.000173	0.0014	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—AKT1—malignant glioma	0.000172	0.00138	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00017	0.00137	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—RAF1—malignant glioma	0.000168	0.00136	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CXCR3—malignant glioma	0.000168	0.00136	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—ERBB2—malignant glioma	0.000166	0.00134	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—KDR—malignant glioma	0.000166	0.00134	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—RTEL1—malignant glioma	0.000164	0.00132	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000164	0.00132	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000163	0.00131	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MET—malignant glioma	0.000162	0.00131	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTP1—malignant glioma	0.000162	0.00131	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—RAF1—malignant glioma	0.000162	0.0013	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	0.00016	0.00129	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CB—malignant glioma	0.000158	0.00127	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—NOTCH1—malignant glioma	0.000156	0.00126	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000156	0.00126	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—BDKRB2—malignant glioma	0.000154	0.00124	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000152	0.00122	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PTPN11—malignant glioma	0.00015	0.00121	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—BRAF—malignant glioma	0.00015	0.00121	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000148	0.0012	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PPARG—malignant glioma	0.000148	0.00119	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—MDM2—malignant glioma	0.000147	0.00119	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—RAF1—malignant glioma	0.000147	0.00118	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LATS1—malignant glioma	0.000146	0.00118	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000146	0.00118	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MMP9—malignant glioma	0.000143	0.00115	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.00014	0.00113	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—AKT2—malignant glioma	0.00014	0.00113	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—KNG1—malignant glioma	0.00014	0.00113	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.00014	0.00113	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MMP2—malignant glioma	0.000136	0.00109	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.00013	0.00105	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—FGF2—malignant glioma	0.000129	0.00104	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—VEGFA—malignant glioma	0.000128	0.00103	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCR4—malignant glioma	0.000128	0.00103	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—MDM2—malignant glioma	0.000125	0.00101	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—RAF1—malignant glioma	0.000125	0.00101	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—RAF1—malignant glioma	0.00012	0.000968	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—ERBB2—malignant glioma	0.000119	0.000958	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.000119	0.000958	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000119	0.000957	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCR4—malignant glioma	0.000116	0.000936	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—EGFR—malignant glioma	0.000115	0.00093	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—malignant glioma	0.000111	0.000893	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—KRAS—malignant glioma	0.000109	0.000879	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CXCL8—malignant glioma	0.000105	0.000849	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—KRAS—malignant glioma	0.000105	0.000844	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MMP9—malignant glioma	0.000102	0.000821	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000102	0.00082	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MDK—malignant glioma	9.9e-05	0.000798	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—malignant glioma	9.61e-05	0.000775	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCR3—malignant glioma	9.5e-05	0.000766	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DTX1—malignant glioma	9.44e-05	0.000761	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—COX8A—malignant glioma	9.43e-05	0.00076	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—VEGFA—malignant glioma	9.15e-05	0.000738	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—STAT3—malignant glioma	9.06e-05	0.00073	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—F2—malignant glioma	9.04e-05	0.000729	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—BDKRB2—malignant glioma	8.69e-05	0.000701	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCR3—malignant glioma	8.63e-05	0.000696	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	8.37e-05	0.000675	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—EGFR—malignant glioma	8.23e-05	0.000664	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ASMT—malignant glioma	8.02e-05	0.000646	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—KNG1—malignant glioma	7.91e-05	0.000638	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—BDKRB2—malignant glioma	7.89e-05	0.000636	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—RAF1—malignant glioma	7.88e-05	0.000635	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TNF—malignant glioma	7.84e-05	0.000632	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—KRAS—malignant glioma	7.78e-05	0.000627	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—BCAN—malignant glioma	7.54e-05	0.000608	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SUFU—malignant glioma	7.5e-05	0.000605	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HEY2—malignant glioma	7.41e-05	0.000597	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GFAP—malignant glioma	7.24e-05	0.000583	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—KNG1—malignant glioma	7.18e-05	0.000579	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SPHK1—malignant glioma	7e-05	0.000565	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HEY1—malignant glioma	6.86e-05	0.000553	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCR4—malignant glioma	6.86e-05	0.000553	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	6.72e-05	0.000542	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HIST1H3B—malignant glioma	6.66e-05	0.000537	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CXCL8—malignant glioma	6.37e-05	0.000514	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MMP3—malignant glioma	6.36e-05	0.000513	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—JAG2—malignant glioma	6.08e-05	0.000491	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—IDH2—malignant glioma	6.08e-05	0.00049	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—AKT1—malignant glioma	5.84e-05	0.000471	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP2B6—malignant glioma	5.71e-05	0.000461	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—IDH1—malignant glioma	5.22e-05	0.000421	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—H3F3A—malignant glioma	5.15e-05	0.000415	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—F2—malignant glioma	5.11e-05	0.000412	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCR3—malignant glioma	5.1e-05	0.000411	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SPHK1—malignant glioma	5.06e-05	0.000408	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—YWHAE—malignant glioma	4.96e-05	0.0004	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NTRK2—malignant glioma	4.96e-05	0.0004	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP2C18—malignant glioma	4.95e-05	0.000399	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FLT1—malignant glioma	4.94e-05	0.000398	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DUSP6—malignant glioma	4.92e-05	0.000396	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CG—malignant glioma	4.89e-05	0.000394	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—JAG1—malignant glioma	4.85e-05	0.000391	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOTCH3—malignant glioma	4.83e-05	0.00039	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FBXW7—malignant glioma	4.75e-05	0.000383	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—BDKRB2—malignant glioma	4.66e-05	0.000376	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—F2—malignant glioma	4.64e-05	0.000374	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AKT2—malignant glioma	4.47e-05	0.000361	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CG—malignant glioma	4.44e-05	0.000358	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PTPN11—malignant glioma	4.36e-05	0.000352	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOTCH2—malignant glioma	4.33e-05	0.00035	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CD—malignant glioma	4.3e-05	0.000347	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KNG1—malignant glioma	4.24e-05	0.000342	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AKT2—malignant glioma	4.06e-05	0.000328	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NTRK1—malignant glioma	4.04e-05	0.000326	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTT1—malignant glioma	4.01e-05	0.000323	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CD—malignant glioma	3.9e-05	0.000315	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MMP3—malignant glioma	3.76e-05	0.000303	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTGS1—malignant glioma	3.75e-05	0.000303	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CB—malignant glioma	3.75e-05	0.000302	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDKN2B—malignant glioma	3.73e-05	0.0003	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTK2—malignant glioma	3.62e-05	0.000292	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCL8—malignant glioma	3.6e-05	0.00029	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HES1—malignant glioma	3.55e-05	0.000287	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NCOR1—malignant glioma	3.53e-05	0.000285	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—BCHE—malignant glioma	3.49e-05	0.000281	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—RAF1—malignant glioma	3.49e-05	0.000281	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC5A5—malignant glioma	3.45e-05	0.000278	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IL2—malignant glioma	3.44e-05	0.000278	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	3.4e-05	0.000274	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	3.38e-05	0.000273	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SPP1—malignant glioma	3.28e-05	0.000265	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	3.27e-05	0.000264	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL2—malignant glioma	3.13e-05	0.000252	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TERT—malignant glioma	3.11e-05	0.000251	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PDGFB—malignant glioma	3.04e-05	0.000245	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGFR1—malignant glioma	3.02e-05	0.000244	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HIF1A—malignant glioma	2.98e-05	0.00024	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CAV1—malignant glioma	2.88e-05	0.000232	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KDR—malignant glioma	2.85e-05	0.00023	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTP1—malignant glioma	2.78e-05	0.000224	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—F2—malignant glioma	2.74e-05	0.000221	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FN1—malignant glioma	2.74e-05	0.000221	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—BAD—malignant glioma	2.71e-05	0.000218	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CAT—malignant glioma	2.7e-05	0.000218	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	2.68e-05	0.000216	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CD80—malignant glioma	2.63e-05	0.000212	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APC—malignant glioma	2.62e-05	0.000212	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	2.62e-05	0.000212	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EGF—malignant glioma	2.59e-05	0.000209	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTPN11—malignant glioma	2.58e-05	0.000208	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NCOR1—malignant glioma	2.55e-05	0.000206	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—BRAF—malignant glioma	2.47e-05	0.000199	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKT2—malignant glioma	2.4e-05	0.000194	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EGFR—malignant glioma	2.39e-05	0.000193	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	2.31e-05	0.000186	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	2.28e-05	0.000184	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—KRAS—malignant glioma	2.26e-05	0.000182	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGF2—malignant glioma	2.21e-05	0.000178	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CAV1—malignant glioma	2.08e-05	0.000168	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	2.07e-05	0.000167	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MDM2—malignant glioma	2.07e-05	0.000167	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RAF1—malignant glioma	2.06e-05	0.000166	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ERBB2—malignant glioma	2.04e-05	0.000164	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	2.01e-05	0.000162	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCL8—malignant glioma	1.93e-05	0.000156	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.89e-05	0.000153	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	1.87e-05	0.00015	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CASP3—malignant glioma	1.85e-05	0.000149	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL2—malignant glioma	1.85e-05	0.000149	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPARG—malignant glioma	1.83e-05	0.000147	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MMP9—malignant glioma	1.75e-05	0.000141	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTEN—malignant glioma	1.74e-05	0.00014	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AKT1—malignant glioma	1.69e-05	0.000137	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.67e-05	0.000134	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VEGFA—malignant glioma	1.57e-05	0.000127	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—STAT3—malignant glioma	1.55e-05	0.000125	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.45e-05	0.000117	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MYC—malignant glioma	1.44e-05	0.000116	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTGS2—malignant glioma	1.44e-05	0.000116	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EGFR—malignant glioma	1.41e-05	0.000114	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KRAS—malignant glioma	1.33e-05	0.000108	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTEN—malignant glioma	1.25e-05	0.000101	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	1.23e-05	9.88e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TP53—malignant glioma	1.19e-05	9.56e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKT1—malignant glioma	1e-05	8.07e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CA—malignant glioma	8.85e-06	7.14e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AKT1—malignant glioma	7.23e-06	5.83e-05	CbGpPWpGaD
